Pilot Study Assessing Breast Temperature in Breast Cancer Patients
Pilot Study Assessing Cutaneous Breast Temperature in the Setting of Mastectomy and Reconstruction
1 other identifier
interventional
52
1 country
1
Brief Summary
Our investigators plan to measure the skin on the breast six months after breast reconstruction. The non-reconstructed breast will be used as the control for subject with unilateral reconstruction only. For those who have BILATERAL reconstruction, a core temperature will be obtained from the ear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2017
CompletedStudy Start
First participant enrolled
December 5, 2017
CompletedFirst Posted
Study publicly available on registry
December 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 7, 2019
CompletedJanuary 8, 2019
January 1, 2019
1.1 years
December 5, 2017
January 7, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in skin temperature after breast reconstruction
Temperature measurements
6 months after surgery
Study Arms (2)
Unilateral breast reconstruction
ACTIVE COMPARATORTemperature measurements are obtained from the reconstructed breast and compared to the non-reconstructed breast.
Bilateral breast reconstruction
EXPERIMENTALTemperature measurements are obtained from both reconstructed breasts and the core temperature is measured as well for comparison.
Interventions
Multiple measurements will be obtained from the ear, chest, breast, abdomen, and hands.
Eligibility Criteria
You may qualify if:
- For post-reconstruction patients: all patients who have undergone mastectomy and breast reconstruction at Duke and are seen in clinic no sooner than 3 months after reconstruction and no more than 5 years after reconstruction.
You may not qualify if:
- Metastatic malignancy of any kind.
- Subjects with a history of breast implant augmentation prior to mastectomy and reconstruction.
- Subjects who cannot give an informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27708, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Hollenbeck, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2017
First Posted
December 18, 2017
Study Start
December 5, 2017
Primary Completion
January 7, 2019
Study Completion
January 7, 2019
Last Updated
January 8, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share